Skip to main content
main-content
Top

16-12-2019 | Renal cell carcinoma | Video | Article

Axel Merseburger: Recent developments in metastatic renal cell carcinoma

Skip to sections on

  • Adjuvant treatment (2:07)
  • Biomarkers for immunotherapy (3:15)

Funding

This independent video interview was supported by an educational grant from Pfizer and Merck KGaA.

<< Back to the immunotherapy in advanced renal cell carcinoma hub

Related topics

Image Credits